Addressing nonadherence in the schizophrenic population

Journal of Pharmacy Practice

Volumn 19, Issue 6, 2006, Pages 361-368

  Singh, Angela C ^a   Massey, Angela J ^a   Thompson, Michael D ^a   Rappa, Leonard R ^a   Honeywell, Marlon S ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

Addressing; Disease; Factors; Nonadherence; Psychosocial; Schizophrenia; Strategies; Treatment

Indexed keywords

ARIPIPRAZOLE; CHLORPROMAZINE; CLOZAPINE; FLUPHENAZINE; FLUPHENAZINE DECANOATE; HALOPERIDOL; HALOPERIDOL DECANOATE; LOXAPINE; LOXAPINE SUCCINATE; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; THIORIDAZINE; TILAFON; TIOTIXENE; TRIFLUOPERAZINE; UNCLASSIFIED DRUG; ZIPRASIDONE;

DISEASE COURSE; DISEASE SEVERITY; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG SUBSTITUTION; HUMAN; OPTIMAL DRUG DOSE; PATIENT COMPLIANCE; POPULATION RESEARCH; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL ASPECT; RECOMMENDED DRUG DOSE; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SOCIAL ASPECT; TREATMENT OUTCOME;

EID: 34249680726     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190007300726     Document Type: Review

References (33)

1. Compton M. Treatment nonadherence among individuals with schizophrenia: risk factors and strategies for improvement. 2006. CME. Available at: medscape.com. Accessed September 23, 2006.
2. Tabor P., Lopez D. Comply with us: improving medication adherence. J Pharm Pract. 2004 ; 17: 167-181.
3. Dolder C., Lacro J., Dunn L., Jeste D. Antipsychotic medication adherence: is there a difference between typical and atypical agents? Am J Psychiatry. 2002 ; 159: 103-108.
4. Zygmunt A., Olfson M., Boyer C., Mechanic D. Interventions to improve medication adherence in schizophrenia. Am J Psychiatry. 2002 ; 159: 1653-1664.
5. Menzin J., Boulanger L., Friedman M., Mackell J., Lloyd J. Treatment adherence associated with conventional and atypical antipsychotics in a large state Medicaid program. Psychiatr Serv. 2003 ; 54: 719-723.
6. Velligan D., Weiden P. Interventions to improve adherence to antipsychotic medications. Psychiatr Times. 2006 ; 23. Available at: www.psychiatrictimes.com/article/showarticle.jhtml?articleId=192202943. Accessed September 23, 2006.
7. Rittmannsberger H., Pachinger T., Keppelmuller P., Wancata J. Medication adherence among psychotic patients before admission to inpatient treatment. Psychiatr Serv. 2004 ; 55: 174-179.
8. Kane J., Leucht S., Carpenter D., Docherty J. The expert consensus guidelines series; optimizing pharmacologic treatment of psychotic disorders. J Clin Psychiatry. 2003 ; 64 (suppl 12). 42-47.
9. Velligan D., Lam F., Ereshefsky L., Miller A. Perspectives on medication adherence and atypical antipsychotic medications. Psychiatr Serv. 2003 ; 54: 665-667.
10. Velligan D., Lam Y., Glahn D., et al. Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr Bull. 2006 ; 32: 724-742.
11. Kane J. Reducing nonadherence: new formulations of antipsychotic medications. Psychiatr Times. 2006 ; 25 (2). Available at: www.psychiatrictimes. com/article/showarticle.jhtml?articleId=18020783. Accessed September 23, 2006.
12. Byerly M., Risher R., Whatley K., et al. A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatr Res. 2005 ; 133: 129-133.
13. Marder S. Overview of partial compliance. J Clin Psychiatry. 2003 ; 64: 3-9.
14. Rickelman B. Anosognosia in individuals with schizophrenia: toward recovery of insight. Issues Mental Health Nurs. 2004 ; 25: 227-242.
15. Agarwal M., Sharma V., Kumar K., Low D. Non-compliance with treatment in patients suffering from schizophrenia: a study to evaluate possible contributing factors. Int J Soc Psychiatry. 1998 ; 44: 92-106.
16. Freudenreich O., Cather C., Evins A., Henderson C., Goff D. Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight. J Clin Psychiatry. 2004 ; 65: 1372-1376.
17. Kikkert M., Schene A., Maarten W., Koeter J., Robson D., Born A. Medication adherence in schizophrenia: exploring patients', carers' and professionals' views. Schizophr Bull. 2006 ; 42: 786-794.
18. Garavan J., Browne S., Gervin M., Lane A., Larkin C., O'Callaghan E. Compliance with neuroleptic medication in outpatients with schizophrenia; relationship to subjective response to neuroleptics; attitudes to medication and insight. Comprehensive Psychiatry. 1998 ; 39: 215-219.
19. Suzuki T., Uchida H., Takeuchi H., et al. Simplifying psychotropic medication regimen into a single night dosage and reducing the dose for patients with chronic schizophrenia. Psychopharmacology. 2005 ; 181: 566-575.
20. Fleischhacker W., Oehl M., Hummer M. Factors influencing compliance in schizophrenia patients. J Clin Psychiatry. 2003 ; 64: 10-13.
21. Yamada K., Watanabe K., Nemoto N., Hidechika F., Chikaraishi C., Yamauchi K. Predication of medication noncompliance in outpatients with schizophrenia: 2-year follow up study. Psychiatr Res. 2006 ; 141: 61-69.
22. Lieberman J., Stroup S., McEvoy J., et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005 ; 353: 1209-1223.
23. Thieda P., Beard S., Richter A., Kane J. An economic review of compliance with medication therapy in the treatment of schizophrenia. Psychiatr Serv. 2003 ; 54: 508-516.
24. Gilmer T., Dolder C., Lacro J., et al. Adherence to treatment with antipsychotic medication and healthcare costs among medicaid beneficiaries with schizophrenia. Am J Psychiatry. 2004 ; 161: 692-699.
25. Olfson M., Mechanic D., Hansell S., Boyer C., Walkup J., Weiden P. Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatr Serv. 2000 ; 51: 216-222.
26. Corriss D., Smith T., Hull J., Lim R., Pratt S., Romanelli S. Interactive risk factors for treatment adherence in a chronic psychotic disorders population. Psychiatr Res. 1999 ; 89: 269-274.
27. Kirsh B., Tate E. Developing a comprehensive understanding of the working alliance in community mental health. Qual Health Res. 2006 ; 16: 1054-1075.
28. Claxton A., Crame J., Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001 ; 23: 1296-1309.
29. Walburn J., Gray R., Gournay K., Quraishi S., David A. Systematic review of patient and nurse attitudes to depot antipsychotic medication. Br J Psychiatry. 2001 ; 179: 300-307.
30. Masand P. A review of pharmacologic strategies for switching to atypical antipsychotics. Prim Care Comp J Clin Psychiatry. 2005 ; 7: 121-129.
31. Lacy CF, Armstrong L, Goldman M, Lance L, eds. Drug Information Handbook. 1 4 th ed. Hudson, Ohio: Lexi-Comp; 2006.
32. Katzung B, Bernstein J, Ransom J, Foltin J, Holton B, eds. Basic & Clinical Pharmacology. 9 th ed. New York, NY: McGraw Hill; 2001.
33. Weiden P. Switching antipsychotics: an updated review with a focus on quetiapine. J Psychopharmacol. 2006 ; 20: 104-118.